1-3 of 3
Levani Odikadze, MD MPH
Close
Sort by
Journal Articles

Characteristics of Sickle Cell Clinic Visits and Hospital Admissions in a Large Urban Academic Hospital

Levani Odikadze, MD MPH, Morgan L. McLemore, MD, Neli Stoyanova, MD, Fuad A El Rassi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5857.
https://doi.org/10.1182/blood-2019-131133
Published: 2019
Journal Articles

Outcomes and Clinical Features of Patients with 1q+ Multiple Myeloma Treated with Lenalidomide, Bortezomib, and Dexamethasone

Timothy M. Schmidt, MD, Nisha Joseph, MD, Levani Odikadze, MD MPH, Leonard Heffner, MD, Craig C Hofmeister, MD MPH, Madhav V Dhodapkar, MD, Vikas A. Gupta, MD PhD, Lawrence H. Boise, PhD, David L. Jaye, MD, Sagar Lonial, MD, Ajay K Nooka, MD MPH, Jonathan L Kaufman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3241.
https://doi.org/10.1182/blood-2018-99-112216
Published: 2018
Journal Articles

Outcomes of Myeloma Patients with Deletion 1p Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Therapy

Levani Odikadze, MD MPH, Nisha Joseph, MD, Timothy M. Schmidt, MD, Leonard Heffner, MD, Craig C Hofmeister, MD MPH, Madhav V Dhodapkar, MD, Vikas A. Gupta, MD PhD, Lawrence H. Boise, PhD, David L. Jaye, MD, Sagar Lonial, MD, Ajay K Nooka, MD MPH, Jonathan L Kaufman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1884.
https://doi.org/10.1182/blood-2018-99-114368
Published: 2018